The global medical industry experienced a 13% decline in the number of electronic medical record (emr) systems-related patent applications in Q3 2023 compared with the previous quarter. The total number of electronic medical record (emr) systems-related grants dropped by 5% in Q3 2023, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q3 2023 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of electronic medical record (emr) systems-related patent applications in the medical industry was 2,076 in Q3 2023, versus 2,398 in the prior quarter.
The top five companies accounted for 7% of patenting activity
Analysis of patenting activity by companies shows that Koninklijke Philips filed the most electronic medical record (emr) systems patents within the medical industry in Q3 2023. The company filed 38 electronic medical record (emr) systems-related patents in the quarter, compared with 83 in the previous quarter. It was followed by Johnson & Johnson with 33 electronic medical record (emr) systems patent filings, Fujifilm (30 filings), and Siemens (27 filings) in Q3 2023.
Patenting activity was driven by China with a 29% share of total patent filings
The largest share of electronic medical record (emr) systems related patent filings in the medical industry in Q3 2023 was in China with 29%, followed by the US (26%) and South Korea (12%). The share represented by China was 10% higher than the 19% share it accounted for in Q2 2023.
For further understanding of GlobalData's Medical Devices: Patents Trends Q3 2023, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.